Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05841680 · ClinicalTrials.gov registry record · NA

A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment

A NA study of Anxiety Disorders, sponsored by Florida International University.

Completed
Registry status
NA
Development phase
59
Enrollment target
1
Study location

NCT05841680 is a NA study of Anxiety Disorders that has completed, run by Florida International University. The registered enrollment target is 59 participants, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05841680, a NA study of Anxiety Disorders, has completed, sponsored by Florida International University.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
1
Study location

Study Summary

Lengthy wait times to access treatment for youth anxiety disorders is a critical issue. To help address this issue, investigators will pursue the following aims in N = 65 families on waitlists for outpatient youth anxiety psychosocial treatment. Aim 1 Pilot Phase: Develop and pilot a single session intervention (SSI) tailored for families on waitlists for outpatient psychosocial treatment for youth anxiety disorders. Investigators will pilot the single session intervention (SSI) with N = 5 families and use cognitive response interviewing to obtain data from parents and children, ensuring the content is understandable and accessible. The SSI will include psychoeducation on the cognitive behavioral conceptualization of anxiety, introduction to self-regulation strategies to manage physiological manifestations of anxiety, and cognitive restructuring of anxiogenic thoughts. The SSI will also involve parents and present strategies on how parents can support their children in managing anxious feelings and thoughts. Investigators will refine the SSI based on these data. Following the Pilot Phase, investigators will enroll an additional N = 60 families and randomize them to either the SSI (n = 30) or waitlist control (n = 30). Aim 2 Test Phase Acceptability, and Satisfaction: Examine acceptability of the refined SSI, as well as satisfaction with the SSI. Investigators hypothesize that users will find the module to be acceptable and will report high satisfaction. Aim 3 Test Phase Anxiety Outcomes: Demonstrate reductions in youth anxiety symptom severity. Investigators hypothesize that anxiety symptom severity and impairment will be significantly lower among youth who receive the refined SSI relative to youth on waitlist control. The main risk or discomfort from this research is that participants might feel uncomfortable answering questions about their behavior and feelings. Another possible risk is breach of confidentiality that could identify a participant as having elevated

Conditions Studied

Interventions

  • BEHAVIORAL SSI Module

Study Locations (1)

Florida

  • Florida International University - Coral Gables

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2023-02-10
Est. Completion 2025-10-01
Phase NA

Sponsor

Florida International University

89 total trials

What the Registry Record Tells You About NCT05841680

The ClinicalTrials.gov registry entry for NCT05841680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (95% lower). The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which SSI Module is the first listed.

NCT05841680 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05841680 about?

NCT05841680 is a clinical study titled "A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment". Lengthy wait times to access treatment for youth anxiety disorders is a critical issue. To help address this issue, investigators will pursue the following aims in N = 65 families on waitlists for outpatient youth anxiety psychosocial treatment. Aim 1 Pilot Phase: Develop and pilot a single session ...

What is the current status of trial NCT05841680?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2023-02-10. Estimated completion is 2025-10-01.

What conditions does trial NCT05841680 study?

This clinical trial studies the following conditions: Anxiety Disorders.

What interventions are being tested in trial NCT05841680?

The interventions under investigation include: SSI Module (BEHAVIORAL).

Who is sponsoring clinical trial NCT05841680?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05841680 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.